Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William C Hahn

Showing results (41-50 of 343) with videos related to

Pageof 35
Sort By:
Trends in Pharmacological Sciences|December 25, 2013
Genomic insights into WNT/β-catenin signalingJoseph Rosenbluh, Xiaoxing Wang, William C Hahn
Critical Reviews in Oncology/Hematology|April 22, 2005
Telomerase: regulation, function and transformationCarolyn K Dong, Kenkichi Masutomi, William C Hahn
Genes & Development|March 17, 2011
Making sense of cancer genomic dataLynda Chin, William C Hahn, Gad Getz, et al.
Trends in Molecular Medicine|July 10, 2004
Functional genetics and experimental models of human cancerJean J Zhao, Thomas M Roberts, William C Hahn
Cell Cycle (Georgetown, Tex.)|February 1, 2008
Liprin alpha1 interacts with PP2A B56gammaJason D Arroyo, Grace M Lee, William C Hahn
The International Journal of Biochemistry & Cell Biology|February 27, 2007
Prostate cancer: Re-focusing on androgen receptor signalingMaria Nieto, Stephen Finn, Massimo Loda, et al.
Cancer Research|December 17, 2010
Identification of PP2A complexes and pathways involved in cell transformationAnna A Sablina, Melissa Hector, Nathalie Colpaert, et al.
Cancer Discovery|September 22, 2011
Clinical implementation of comprehensive strategies to characterize cancer genomes: opportunities and challengesLaura E MacConaill, Paul Van Hummelen, Matthew Meyerson, et al.
Cancer Cell|April 5, 2003
Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cellsSonam Dolma, Stephen L Lessnick, William C Hahn, et al.
Nature Reviews. Cancer|October 29, 2024
The present and future of the Cancer Dependency MapRand Arafeh, Tsukasa Shibue, Joshua M Dempster, et al.
Pageof 35

Showing results (41-50 of 343) with videos related to

Sort By:
Pageof 35
Trends in Pharmacological Sciences|December 25, 2013
Genomic insights into WNT/β-catenin signalingJoseph Rosenbluh, Xiaoxing Wang, William C Hahn
Critical Reviews in Oncology/Hematology|April 22, 2005
Telomerase: regulation, function and transformationCarolyn K Dong, Kenkichi Masutomi, William C Hahn
Genes & Development|March 17, 2011
Making sense of cancer genomic dataLynda Chin, William C Hahn, Gad Getz, et al.
Trends in Molecular Medicine|July 10, 2004
Functional genetics and experimental models of human cancerJean J Zhao, Thomas M Roberts, William C Hahn
Cell Cycle (Georgetown, Tex.)|February 1, 2008
Liprin alpha1 interacts with PP2A B56gammaJason D Arroyo, Grace M Lee, William C Hahn
The International Journal of Biochemistry & Cell Biology|February 27, 2007
Prostate cancer: Re-focusing on androgen receptor signalingMaria Nieto, Stephen Finn, Massimo Loda, et al.
Cancer Research|December 17, 2010
Identification of PP2A complexes and pathways involved in cell transformationAnna A Sablina, Melissa Hector, Nathalie Colpaert, et al.
Cancer Discovery|September 22, 2011
Clinical implementation of comprehensive strategies to characterize cancer genomes: opportunities and challengesLaura E MacConaill, Paul Van Hummelen, Matthew Meyerson, et al.
Cancer Cell|April 5, 2003
Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cellsSonam Dolma, Stephen L Lessnick, William C Hahn, et al.
Nature Reviews. Cancer|October 29, 2024
The present and future of the Cancer Dependency MapRand Arafeh, Tsukasa Shibue, Joshua M Dempster, et al.
Pageof 35